Benefits of nirmatrelvir-ritonavir remain unproven for some populations

被引：0
|
作者：
McDonald, Emily G. [1 ]
Lee, Todd [1 ]
机构：
[1] McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2022年 / 194卷 / 29期
关键词：
D O I：
10.1503/cmaj.146689-l
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1041 / E1041
页数：1
相关论文
共 50 条
  • [21] Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation
    Yan, Lei
    Bui, David
    Li, Yuli
    Rajeevan, Nallakkandi
    Rowneki, Mazhgan
    Berry, Kristin
    Argraves, Stephanie
    Huang, Yuan
    Hynes, Denise M.
    Cunningham, Francesca
    Huang, Grant D.
    Aslan, Mihaela
    Ioannou, George N.
    Bajema, Kristina L.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (03) : 643 - 651
  • [22] Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment
    Charness, Michael E.
    Gupta, Kalpana
    Stack, Gary
    Strymish, Judith
    Adams, Eleanor
    Lindy, David C.
    Mohri, Hiroshi
    Ho, David D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 1045 - 1047
  • [23] Best regimen for elexacaftor/ivacaftor/tezacaftor with nirmatrelvir-ritonavir for COVID-19?
    Reactions Weekly, 2022, 1900 (1) : 4 - 4
  • [24] Pharmacokinetic and pharmacogenomic considerations in managing use of nirmatrelvir-ritonavir and molnupiravir and dermatological treatments
    Chen, Sylvia
    Leong, Wai Fook
    Lee, Sze Sing
    Chowbay, Balram
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2022, 51 (12) : 752 - 754
  • [25] A Case Report of Safe Coadministration of Amiodarone with Short-Term Treatment Nirmatrelvir-Ritonavir
    Sluijters, Alice
    Lemaitre, Florian
    Belkhir, Leila
    Boland, Lidvine
    Haufroid, Vincent
    De Greef, Julien
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (04) : 768 - 769
  • [26] Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization in Adults With Coronavirus Disease 2019
    Shah, Melisa M.
    Joyce, Brendan
    Plumb, Ian D.
    Sahakian, Sam
    Feldstein, Leora R.
    Barkley, Eric
    Paccione, Mason
    Deckert, Joseph
    Sandmann, Danessa
    Hagen, Melissa Briggs
    Gerhart, Jacqueline L.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (01) : 108 - 110
  • [27] Benefits of e-Health Technologies Remain Unproven
    不详
    US PHARMACIST, 2011, 36 (02) : 6 - 6
  • [28] Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19
    Gao, Yuan
    Luo, Zujin
    Ren, Shan
    Duan, Zhonghui
    Han, Ying
    Liu, Huihang
    Gao, Ziwen
    Zhang, Xinyu
    Hu, Zhongjie
    Ma, Yingmin
    JOURNAL OF INFECTION, 2023, 86 (06) : E158 - E160
  • [29] VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19
    Cao, Zhujun
    Gao, Weiyi
    Bao, Hong
    Feng, Haiyan
    Mei, Shuya
    Chen, Peizhan
    Gao, Yueqiu
    Cui, Zhilei
    Zhang, Qin
    Meng, Xianmin
    Gui, Honglian
    Wang, Weijing
    Jiang, Yimei
    Song, Zijia
    Shi, Yiqing
    Sun, Jing
    Zhang, Yifei
    Xie, Qing
    Xu, Yiping
    Ning, Guang
    Gao, Yuan
    Zhao, Ren
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (05): : 406 - 417
  • [30] SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy An Observational Study
    Edelstein, Gregory E.
    Boucau, Julie
    Uddin, Rockib
    Marino, Caitlin
    Liew, May Y.
    Barry, Mamadou
    Choudhary, Manish C.
    Gilbert, Rebecca F.
    Reynolds, Zahra
    Li, Yijia
    Tien, Dessie
    Sagar, Shruti
    Vyas, Tammy D.
    Kawano, Yumeko
    Sparks, Jeffrey A.
    Hammond, Sarah P.
    Wallace, Zachary
    Vyas, Jatin M.
    Barczak, Amy K.
    Lemieux, Jacob E.
    Li, Jonathan Z.
    Siedner, Mark J.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1577 - 1585
12345